Front-Line Treatment in Younger Patients With Multiple Myeloma
To access this article, please choose from the options below
S.V.R. is supported in part by Grants No. CA62242 and CA107476 from the National Cancer Institute, Bethesda, MD. P.S. is supported in part by grants from the Dutch Cancer Foundation CKTO.
PII: S0037-1963(09)00033-X
doi:10.1053/j.seminhematol.2009.02.005
© 2009 Elsevier Inc. All rights reserved.
